Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mortara Instrument developed a comprehensive portfolio of non-invasive diagnostic cardiology devices including ECGs, Holter monitors, stress test systems, ambulatory blood pressure monitors, and patient monitoring solutions. The company’s products were widely adopted in clinical practice globally before its acquisition by Hill-Rom Holdings in early 2017[1][2][9].
No clinical trial results apply as the company does not develop therapeutics.
Its technology has been selected by major CROs such as Medpace for ECG data collection in clinical research settings[6].
The business continues under the Hill-Rom umbrella with ongoing sales of legacy brands like Burdick and Quinton.
Pipeline breadth/pipeline/programs do not apply to this type of company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mortara Instrument.